Steroid-induced myopathy and its significance to respiratory disease: a known disease rediscovered

Skeletal muscle myopathy is a well-known side-effect of systemically administered corticosteroids. In recent years renewed attention is being paid to the involvement of the respiratory muscles and its consequent significance in pulmonary patients. Two different clinical patterns of steroid-induced muscular changes are known. In acute myopathy and atrophy after short term treatment with high doses of steroids, generalized muscle atrophy and rhabdomyolysis occur, including the respiratory muscles. Chronic steroid myopathy, occurring after prolonged treatment with moderate doses, is characterized by the gradual onset of proximal limb muscle weakness and may be accompanied by reduced respiratory muscle force. Animal studies demonstrated diaphragmatic myopathy and atrophy similar to the alterations in peripheral skeletal muscles. Fluorinated steroids induced selective type IIb (fast-twitch glycolytic) fibre atrophy, resulting in changes in contractile properties of the diaphragm. Non-fluorinated steroids may also induce histological, biochemical and functional alterations in the diaphragm. Observations in patients with collagen vascular disorders and with asthma and chronic obstructive pulmonary disease (COPD) underline the potential hazards of treatment with corticosteroids to respiratory muscle structure and function.

This article has been cited by other articles:

				H. Degens, A. K. Swisher, Y. F. Heijdra, P. M. Siu, P. N. Richard Dekhuijzen, and S. E. Alway Apoptosis and Id2 expression in diaphragm and soleus muscle from the emphysematous hamster Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R135 - R144. [Abstract] [Full Text] [PDF]

				M. Hatakenaka, H. Soeda, T. Okafuji, H. Yabuuchi, S. Shiokawa, J. Nishimura, and H. Honda Steroid Myopathy: Evaluation of Fiber Atrophy with T2 Relaxation Time--Rabbit and Human Study Radiology, December 21, 2005; (2005) 2381041720. [Abstract] [Full Text]

				A. Couillard and C. Prefaut From muscle disuse to myopathy in COPD: potential contribution of oxidative stress Eur. Respir. J., October 1, 2005; 26(4): 703 - 719. [Abstract] [Full Text] [PDF]

				W D-C Man, N S Hopkinson, F Harraf, D Nikoletou, M I Polkey, and J Moxham Abdominal muscle and quadriceps strength in chronic obstructive pulmonary disease Thorax, September 1, 2005; 60(9): 718 - 722. [Abstract] [Full Text] [PDF]

				A. C. White, N. Terrin, K. B. Miller, and H. F. Ryan Impaired Respiratory and Skeletal Muscle Strength in Patients Prior to Hematopoietic Stem-Cell Transplantation Chest, July 1, 2005; 128(1): 145 - 152. [Abstract] [Full Text] [PDF]

				J. P Mattson and J. C Martin Emphysema-induced reductions in locomotory skeletal muscle contractile function Exp Physiol, July 1, 2005; 90(4): 519 - 525. [Abstract] [Full Text] [PDF]

				D S Hui, G M Joynt, K T Wong, C D Gomersall, T S Li, G Antonio, F W Ko, M C Chan, D P Chan, M W Tong, et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors Thorax, May 1, 2005; 60(5): 401 - 409. [Abstract] [Full Text] [PDF]

				S. Mathur, W D. Reid, and R. D Levy Exercise Limitation in Recipients of Lung Transplants Physical Therapy, December 1, 2004; 84(12): 1178 - 1187. [Full Text] [PDF]

				A. J. Verheul, C. B. Mantilla, W.-Z. Zhan, M. Bernal, P. N. R. Dekhuijzen, and G. C. Sieck Influence of corticosteroids on myonuclear domain size in the rat diaphragm muscle J Appl Physiol, November 1, 2004; 97(5): 1715 - 1722. [Abstract] [Full Text] [PDF]

				J.P. Mattson, M.D. Delp, and D.C. Poole Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters Eur. Respir. J., May 1, 2004; 23(5): 703 - 707. [Abstract] [Full Text] [PDF]

				A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets Systemic effects of chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2003; 21(2): 347 - 360. [Abstract] [Full Text] [PDF]

				H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047. [Abstract] [Full Text] [PDF]

				M. A. JANTZ and S. A. SAHN Corticosteroids in Acute Respiratory Failure Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1079 - 1100. [Full Text]

				P. Meek Dyspnea . Mechanisms, Assessment, and Management: A Consensus Statement Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 321 - 340. [Full Text]

				R. H. H. Van Balkom, P. N. R. Dekhuijzen, H. T. M. Folgering, J. H. Veerkamp, H. T. Van Moerkerk, J. A. M. Fransen, and C. L. A. Van Herwaarden Anabolic steroids in part reverse glucocorticoid-induced alterations in rat diaphragm J Appl Physiol, May 1, 1998; 84(5): 1492 - 1499. [Abstract] [Full Text] [PDF]